MYRIAD GENETICS INC (MYGN) Income Tax Expense (Benefit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Myriad Genetics Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • Myriad Genetics Inc Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $100 K, a 95.2% decline year-over-year.
  • Myriad Genetics Inc Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$900 K, a 95.6% increase year-over-year.
  • Myriad Genetics Inc annual Income Tax Expense (Benefit) for 2023 was $1.1 M.
  • Myriad Genetics Inc annual Income Tax Expense (Benefit) for 2022 was -$28.6 M, a 4.35% increase from 2021.
  • Myriad Genetics Inc annual Income Tax Expense (Benefit) for 2021 was -$29.9 M, a 50.1% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$900 K $100 K -$2 M -95.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $1.1 M -$1.1 M +$8.7 M +88.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$7.6 M $100 K +$9.2 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$16.8 M $0 +$3.8 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 -$20.6 M $2.1 M +$8 M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$28.6 M -$9.8 M +$26.1 M +72.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$54.7 M -$9.1 M -$24.3 M -160% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$30.4 M -$3.8 M -$4.7 M -522% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$25.7 M -$5.9 M +$4.2 M +41.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$29.9 M -$35.9 M -$23.4 M -187% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$6.5 M $15.2 M +$43.7 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$50.2 M $900 K +$3.9 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 -$54.1 M -$10.1 M +$5.8 M +36.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$59.9 M -$12.5 M -$9.4 M -303% Oct 1, 2020 Dec 31, 2020 10-KT 2021-03-16
Q3 2020 -$50.5 M -$28.5 M -$26.8 M -1576% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$23.7 M -$3 M +$400 K +11.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$24.1 M -$15.9 M -$12.3 M -342% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$11.8 M -$3.1 M -$4.1 M -410% Oct 1, 2019 Dec 31, 2019 10-KT 2021-03-16
Q3 2019 -$7.7 M -$1.7 M -$3.3 M -206% Jul 1, 2019 Sep 30, 2019 10-KT 2021-03-16
Q2 2019 -$4.4 M -$3.4 M -$6.9 M -197% Apr 1, 2019 Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $2.5 M -$3.6 M -$7.9 M -184% Jan 1, 2019 Mar 31, 2019 10-KT 2021-03-16
Q4 2018 $10.4 M $1 M +$26.3 M Oct 1, 2018 Dec 31, 2018 10-KT 2021-03-16
Q3 2018 -$15.9 M $1.6 M -$2.9 M -64.4% Jul 1, 2018 Sep 30, 2018 10-KT 2021-03-16
Q2 2018 -$13 M $3.5 M -$2.3 M -39.7% Apr 1, 2018 Jun 30, 2018 10-K 2019-08-13
Q1 2018 -$10.7 M $4.3 M +$1.3 M +43.3% Jan 1, 2018 Mar 31, 2018 10-K 2019-08-13
Q4 2017 -$12 M -$25.3 M -$31.5 M -508% Oct 1, 2017 Dec 31, 2017 10-K 2019-08-13
Q3 2017 $19.5 M $4.5 M -$1.1 M -19.6% Jul 1, 2017 Sep 30, 2017 10-K 2019-08-13
Q2 2017 $20.6 M $5.8 M -$3.3 M -36.3% Apr 1, 2017 Jun 30, 2017 10-K 2018-08-24
Q1 2017 $23.9 M $3 M -$5.6 M -65.1% Jan 1, 2017 Mar 31, 2017 10-K 2018-08-24
Q4 2016 $29.5 M $6.2 M -$1.7 M -21.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-08-24
Q3 2016 $31.2 M $5.6 M -$7.6 M -57.6% Jul 1, 2016 Sep 30, 2016 10-K 2018-08-24
Q2 2016 $38.8 M $9.1 M -$7.5 M -45.2% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-24
Q1 2016 $46.3 M $8.6 M -$5.5 M -39% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $51.8 M $7.9 M -$6 M -43.2% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-08
Q3 2015 $57.8 M $13.2 M +$3.3 M +33.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $54.5 M $16.6 M -$2.28 M -12.1% Apr 1, 2015 Jun 30, 2015 10-K 2018-08-24
Q1 2015 $56.8 M $14.1 M -$6.47 M -31.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 $63.3 M $13.9 M -$19.9 M -58.9% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-03
Q3 2014 $83.1 M $9.9 M -$18.5 M -65.1% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-04
Q2 2014 $102 M $18.9 M -$4.24 M -18.3% Apr 1, 2014 Jun 30, 2014 10-K 2016-08-10
Q1 2014 $106 M $20.6 M -$776 K -3.64% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $107 M $33.8 M +$11.8 M +53.9% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-04
Q3 2013 $94.8 M $28.4 M +$8.68 M +44.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 $86.1 M $23.1 M +$3.79 M +19.6% Apr 1, 2013 Jun 30, 2013 10-K 2015-08-12
Q1 2013 $82.3 M $21.3 M +$3.48 M +19.5% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q4 2012 $78.8 M $21.9 M +$3.46 M +18.7% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-05
Q3 2012 $75.4 M $19.7 M +$2.98 M +17.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $72.4 M $19.3 M +$3.26 M +20.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-08-13
Q1 2012 $69.1 M $17.9 M +$3.49 M +24.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 $65.6 M $18.5 M +$3.62 M +24.4% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-06
Q3 2011 $62 M $16.7 M +$3.07 M +22.5% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 $58.9 M $16.1 M Apr 1, 2011 Jun 30, 2011 10-K 2013-08-14
Q1 2011 $14.4 M +$13.1 M +1069% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-02
Q4 2010 $14.9 M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-01
Q3 2010 $13.6 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-02
Q1 2010 $1.23 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.